Renovascular hypertension in 2007: Where are we now?

Current Cardiology Reports

Volumn 9, Issue 6, 2007, Pages 453-461

  Textor, Stephen C ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANTIHYPERTENSIVE THERAPY; ATHEROSCLEROSIS; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; DIABETES MELLITUS; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; EPIDEMIOLOGICAL DATA; FIBROMUSCULAR DYSPLASIA; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RENAL ARTERY; RENAL ARTERY ANEURYSM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR DISEASE; RENOVASCULAR HYPERTENSION; REVASCULARIZATION; REVIEW; STENT; SURGICAL EQUIPMENT; SURGICAL RISK; VASCULAR DISEASE;

ANTIHYPERTENSIVE AGENTS; FIBROMUSCULAR DYSPLASIA; HUMANS; HYPERTENSION, RENOVASCULAR; RENAL ARTERY OBSTRUCTION; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; STENTS;

EID: 36048929760     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02938389     Document Type: Review

References (50)

1. Murphy TP, Soares G, Kim M: Increase in utilization of percutaneous renal artery interventions by Medicare beneficiaries, 1996-2000. AJR Am J Roentgenol 2004, 183:561-568.
2. Hirsch AT, Haskal ZJ, Hertzer NR, et al.: ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines: summary of recommendations J Vasc Interv Radiol 2006, 17:1383-1397.
3. White CJ, Jaff MR, Haskal ZJ, et al.: Indications for renal arteriography at the time of coronary arteriography. Circulation 2006, 114:1892-1895.
4. Balk E, Raman G, Chung M, et al.: Effectiveness of management strategies for renal artery stenosis: a systematic review. Ann Intern Med 2006, 145:901-912.
5. Cooper CJ, Murphy TP, Matsumoto A, et al.: Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J 2006, 152:59-66.
6. Garovic V, Textor SC: Renovascular hypertension: current concepts. Semin Nephrol 2005, 25:261-271.
7. Little MA, O'Brien E, Owens P, et al.: A longitudinal study of the yield and clinical utility of a specifically designed secondary hypertension investigation protocol. Ren Fail 2003, 25:709-717.
8. Alhadad A, Mattiasson I, Ivancev K, et al.: Revascularisation of renal artery stenosis caused by fibromuscular dysplasia: effects on blood pressure during 7-year follow-up are influenced by duration of hypertension and branch artery stenosis. J Hum Hypertens 2005, 19:761-767.
9. Carmo M, Bower TC, Mozes G, et al.: Surgical management of renal fibromuscular dysplasia: challenges in the endovascular era. Ann Vasc Surg 2005, 19:208-217.
10. Kumar A, Dubey D, Bansal P, et al.: Surgical and radiological management of renovascular hypertension in a developing country. J Urol 2003, 170:727-730.
11. Edwards MS, Craven TE, Burke GL, et al.: Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study. Arch Intern Med 2005, 165:207-213.
12. Kalra PA, Guo H, Kausz AT, et al.: Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization and prognosis. Kidney Int 2005, 68:293-301.
13. Buller CE, Nogareda JG, Ramanathan K, et al.: The profile of cardiac patients with renal artery stenosis. J Am Coll Cardiol 2004, 43:1606-1613.
14. Grisk O, Rettig R: Interactions between the sympathetic nervous system and the kidneys in arterial hypertension. Cardiovasc Res 2004, 61:238-246.
15. De Bruyne B, Manoharan G, Pijls NH, et al.: Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol 2006, 48:1851-1855.
16. Crowley SD, Gurley SB, Oliverio MI, et al.: Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest 2005, 115:1092-1099.
17. Jung O, Schreiber JG, Geiger H, et al.: gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation 2004, 109:1795-1801.
18. Welch WJ, Mendonca M, Aslam S, Wilcox CS: Roles of oxidative stress and AT1 receptors in renal hemodynamics and oxygenation in the postclipped 2K,1C kidney. Hypertension 2003, 41:692-696.
19. Parildar M, Parildar Z, Oran I, et al.: Nitric oxide and oxidative stress in atherosclerotic renovascular hypertension: effect of endovascular treatment. J Vasc Interv Radiol 2004, 14:887-892.
20. Chade AR, Rodriguez-Porcel M, Grande JP, et al.: Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis. Arterioscler Thromb Vasc Biol 2003, 23:1295-1301.
21. Alphons Wierema TK, Kroon AA, deLeeuw PW: Poor performance of diagnostic tests for atherosclerotic renal artery stenosis: discrepancies between stenosis and renal function. Nephrol Dial Transplant 2007, 22:689-692.
22. Ives NJ, Wheatley K, Stowe RL, et al.: Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials. Nephrol Dial Transplant 2003, 18:298-304.
23. van Jaarsveld BC, Krijnen P, Pieterman H, et al.: The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000, 342:1007-1014.
24. Silva JA, Chan AW, White CJ, et al.: Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis. Circulation 2005, 111:328-333.
25. Gandy SJ, Sudarshan TA, Sheppard DG, et al.: Dynamic MRI contrast enhancement of renal cortex: a functional assessment of renovascular disease in patients with renal artery stenosis. J Magn Reson Imaging 2003, 18:461-466.
26. Tan KT, van Beek EJ, Brown PW, et al.: Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis. Clin Radiol 2002, 57:617-624.
27. Marckmann P, Skov L, Rossen K, et al.: Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006, 17:2359-2362.
28. Vasbinder GB, Nelemans PJ, Kessels AG, et al.: Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med 2004, 141:674-682.
29. Radermacher J, Haller H: The right diagnostic work-up: investigating renal and renovascular disorders. J Hypertens 2003, 21(Suppl 2):S19-S24.
30. Zeller T, Frank U, Muller C, et al.: Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation 2003, 108:2244-2249.
31. Textor SC: Pitfalls in imaging for renal artery stenosis. Ann Intern Med 2004, 141:730-731.
32. Murphy TP, Cooper CJ, Dworkin LD, et al.: The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods. J Vasc Interv Radiol 2005, 16:1295-1300.
33. Hanzel G, Balon H, Wong O, et al.: Prospective evaluation of aggressive medical therapy for atherosclerotic renal artery stenosis, with renal artery stenting reserved for previously injured heart, brain or kidney. Am J Cardiol 2005, 96:1322-1327.
34. Pearce JD, Craven BL, Craven TE, et al.: Progression of atherosclerotic renovascular disease: a prospective, population-based study. J Vasc Surg 2006, 44:955-963.
35. Kiykim AA, Boz M, Ozer C, et al.: Two episodes of anuria and acute pulmonary edema in a losartan-treated patient with solitary kidney. Heart Vessels 2004, 19:52-54.
36. Dworkin LD, Jamerson KA: Is renal artery stenting the correct treatment of renal artery stenosis? Case against angioplasty and stenting of renal artery stenosis. Circulation 2007, 115:271-276.
37. Cooper CJ, Murphy TP: Is renal artery stenting the correct treatment of renal artery stenosis? The case for renal artery stenting of renal artery stenosis. Circulation 2007, 115:263-269.
38. Dorros G, Jaff M, Mathiak L, He T; Multicenter Registry Participants: Multicenter Palmaz stent renal artery stenosis revascularization registry report: four-year follow-up of 1,058 successful patients. Catheter Cardiovasc Interv 2002, 55:182-188.
39. Nordmann AJ, Woo K, Parkes R, Logan AG: Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. Am J Med 2003, 114:44-50.
40. White CJ: Catheter-based therapy for atherosclerotic renal artery stenosis. Circulation 2006, 113:1464-1473.
41. Mistry S, Ives N, Harding J, et al.: Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far. J Hum Hypertens 2007, 21:511-515.
42. Bax L, Mali WP, Buskens E, et al.: The benefit of STent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal Artery: the STAR study: rationale and study design. J Nephrol 2003, 16:807-812.
43. Tobe SW, Atri M, Perkins N, et al.: Renal atherosclerotic revascularization evaluation (RAVE study): study protocol of a randomized trial. BMC Nephrol 2007, 8:4.
44. Scarpioni R, Michieletti E, Cristinelli L, et al.: Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression. The rationale and study design of a prospective, multicenter and randomized trial (NITER). J Nephrol 2005, 18:423-428.
45. Ivanovic V, McKusick MA, Johnson CM, et al.: Renal artery stent placement: complications at a single tertiary care center. J Vasc Interv Radiol 2003, 14:217-225.
46. Rocha-Singh K, Jaff MR, Rosenfield K; ASPIRE-2 Trial Investigators: Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study. J Am Coll Cardiol 2005, 46:776-783.
47. Hiramoto J, Hansen KJ, Pan XM, et al.: Atheroemboli during renal artery angioplasty: an ex-vivo study. J Vasc Surg 2005, 41:1026-1030.
48. Holden A, Hill A, Jaff MR, Pilmore H: Renal artery stent revascularization with embolic protection in patients with ischemic nephropathy. Kidney Int 2007, 70:948-955.
49. Cooper C, et al.: Late breaking clinical trials [abstract]. Presented at the 56th Annual Scientific Session of the American College of Cardiology. New Orleans, LA; March 24-27, 2007.
50. Garovic V, Textor SC: Renovascular hypertension and ischemic nephropathy. Circulation 2005, 112:1362-1374.